HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.

AbstractBACKGROUND:
For the detection of malignant mesothelioma no single biomarker with reasonable sensitivity and specificity has been described so far. Mesothelin, the most prominent blood-based biomarker, is characterized by high specificity but low sensitivity. It might be reasonable to combine biomarkers of different molecular classes in order to improve the overall performance. The aim of this study was to assess the performance of the combination of mesothelin and miR-103a-3p as blood-based biomarker for mesothelioma.
METHODS/PRINCIPAL FINDINGS:
Mesothelin concentration in plasma and miR-103a-3p levels in the cellular blood fraction were analyzed in 43 male mesothelioma patients and 52 male controls formerly exposed to asbestos. For the discrimination of epithelioid and biphasic mesothelioma from asbestos-exposed controls mesothelin and miR-103a-3p showed 74% and 89% sensitivity and 85% and 63% specificity, respectively. For the combination of mesothelin and miR-103a-3p a sensitivity of 95% and a specificity of 81% were calculated.
CONCLUSIONS/SIGNIFICANCE:
The results of this study show that the combination of mesothelin and miR-103a-3p improves the diagnostic performance of individual blood-based biomarker to detect malignant mesothelioma. The obtained results indicate that the use of biomarkers of different molecular classes might be a reasonable approach to assemble a biomarker panel.
AuthorsDaniel G Weber, Swaantje Casjens, Georg Johnen, Oleksandr Bryk, Irina Raiko, Beate Pesch, Jens Kollmeier, Torsten T Bauer, Thomas Brüning
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e114483 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25469901 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • GPI-Linked Proteins
  • MIRN103 microRNA, human
  • MicroRNAs
  • Mesothelin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood)
  • GPI-Linked Proteins (blood)
  • Humans
  • Lung Neoplasms (blood, diagnosis)
  • Male
  • Mesothelin
  • Mesothelioma (blood, diagnosis)
  • Mesothelioma, Malignant
  • MicroRNAs (blood)
  • Middle Aged
  • ROC Curve

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: